Eloxx Pharmaceuticals' Series C - II Round

Eloxx Pharmaceuticals raised a round of funding on June 26, 2017.

Eloxx Pharmaceuticals (NASDAQ:ELOX) is a clinical stage company developing therapeutics for genetic diseases caused by non-sense mutations.…

Articles about Eloxx Pharmaceuticals' Series C - II Round: